Grelet, Simon
Link, Laura A.
Howley, Breege
Obellianne, Clémence
Palanisamy, Viswanathan
Gangaraju, Vamsi K.
Diehl, J. Alan
Howe, Philip H. http://orcid.org/0000-0002-1358-1313
Article History
Received: 1 March 2017
Accepted: 19 July 2017
First Online: 21 August 2017
Change Date: 13 November 2017
Change Type: Update
Change Details: In this Addendum, the authors include western blot data using a C-terminal PNUTS antibody. This is important in that an annotation of the alternative spliced form of PNUTS, denoted in the UCSC genome browser (ExternalRef removed), depicts it as a non-coding RNA. However, downstream of the alternative splice site is an alternative AUG located in frame in the PNUTS ORF at position 1039. The potential for a protein product of ∼61 kDa being generated from this AUG was examined experimentally using a C-terminal raised antibody to PNUTS to exclude the possibility that the N-terminal deletion of the splice isoform was not the reason that the predicted 61-kDa protein was not detected in cells using an N-terminal generated antibody. The results presented here confirm our previous results using the N-terminal PNUTS antibody and originally presented in Supplementary Fig. 2b of the Article; namely, that this predicted ∼61-kDa product is not detectable in cells under the conditions used, even under conditions of overexpression. Figure (see PDF): lncRNA-PNUTS does not encode for a N-terminal truncated-protein product. The result of a western blot analysis of PNUTS protein expression in CaCo-2 cells upon transient lncRNA-PNUTS expression (3 days) or TGFβ treatment (1 day) is shown. The C-terminal antibody used was EPR11706 (Abcam: Ab173285; clone PPP1R10; 1/1000 dilution) raised against the C-terminal region of the PNUTS protein (amino acids 550–650). The western blot protocol and extracts used in this experiment were identical to those described in Supplementary Fig. 2 of the original Article.
Competing interests
: The authors declare no competing financial interests.